Alnylam Pharmaceuticals
ALNY
#622
Rank
ยฃ25.18 B
Marketcap
ยฃ195.27
Share price
2.75%
Change (1 day)
36.74%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Total assets

Total assets on the balance sheet as of September 2024 : ยฃ3.34 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company's total assets are ยฃ3.34 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Alnylam Pharmaceuticals - Total assets on balance sheet (from 2003 to 2024)

Total assets by year

Year Total assets Change
2023-12-31ยฃ3.00 B2.55%
2022-12-31ยฃ2.93 B8.61%
2021-12-31ยฃ2.69 B7.98%
2020-12-31ยฃ2.49 B36.85%
2019-12-31ยฃ1.82 B47.23%
2018-12-31ยฃ1.24 B-15.94%
2017-12-31ยฃ1.47 B44.21%
2016-12-31ยฃ1.02 B9.39%
2015-12-31ยฃ0.93 B34.93%
2014-12-31ยฃ0.69 B171.99%
2013-12-31ยฃ0.25 B43.32%
2012-12-31ยฃ0.17 B-1.92%
2011-12-31ยฃ0.18 B-28.8%
2010-12-31ยฃ0.25 B-14.36%
2009-12-31ยฃ0.29 B-21.4%
2008-12-31ยฃ0.37 B52.26%
2007-12-31ยฃ0.24 B102.86%
2006-12-31ยฃ0.12 B114.85%
2005-12-31ยฃ57.03 M65.62%
2004-12-31ยฃ34.43 M75.08%
2003-12-31ยฃ19.66 M95.74%
2002-12-31ยฃ10.04 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
ยฃ0.90 B-72.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ29.78 B 790.41%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.86 B-14.39%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.79 B-46.35%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ74.59 M-97.77%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ82.36 B 2,361.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ110.66 B 3,207.82%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ33.22 B 893.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel